Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390509

Chief Financial Officer sold 10,810 shares at an average $32.36 ($349,821)

From the SEC's structured data for this filing

Trades in this filing

FRATES JAMES M · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-10 Sale : show line 1 in the form −9,768 $32.27 $315,195 234,667 D
2026-09-10 Sale : show line 2 in the form −1,042 $33.23 $34,626 233,625 D
Open-market sales · 10,810 sh · avg $32.36 · $349,821
Loading xslF345X06/ownership.xml…